Pacjent z zespołem Li-Fraumeni w gabinecie stomatologicznym – opis przypadku

Piśmiennictwo

1. Valdez J.M., Nichols K.E., Kesserwan C.: Li-Fraumeni syndrome: a paradigm for the understanding of hereditary cancer predisposition. „Br J Haematol”, 2017, 176, 539-552.
2. Aedma S.K., Kasi A.: Li-Fraumeni Syndrome. [In:] StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2021.
3. Sejben A. et al.: Li-Fraumeni syndrome. „Orv Hetil”, 2019 Feb, 160 (6), 228-234.
4. Kratz C.P. et al.: Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome. „Clin Cancer Res”, 2017 Jun, 23 (11) e38-e45.
5. McBride K.A. et al.: Li-Fraumeni syndrome: cancer risk assessment andclinical management. „Nat Rev Clin Oncol”, 2014 May, 11 (5), 260-71.
6. Schneider K. et al.: Li-Fraumeni Syndrome. [W:] GeneReviews^® [Internet]. Seattle (WA): University of Washington, Seattle.
7. Mai P.L. et al.: Risks of First and Subsequent Cancers Among TP53 Mutation Carriers in the National Cancer Institute Li-Fraumeni Syndrome Cohort. „Cancer”, 2016 Dec, 1, 122 (23), 3673-3681.
8. Mai P.L. et al.: Li-Fraumeni syndrome: report of a clinical research workshop and creation of a research consortium. „Cancer Genet.”, 2012 Oct, 205 (10), 479-87.
9. Klein J.D., Kupferman M.E.: Li-Fraumeni syndrome presenting as mucosal melanoma: Case report andtreatment considerations. „Head Neck.”, 2017 Feb, 39 (2), E20-E22.
10. Ossa C.A., Molina G., Cock-Rada A.M.: Li-Fraumeni syndrome. „Biomedica”, 2016 Jun, 3, 36 (2), 182-7.
11. Dutzmann C.M. et al.: Update on Li-Fraumeni syndrome. „Review Pathologe.”, 2019 Nov, 40 (6), 592-599.
12. Gargallo P. et al.: Li-Fraumeni syndrome heterogeneity. „Clin Transl Oncol”, 2020 Jul, 22 (7), 978-988.
13. Dalkiz M., Dalkiz A.S.: The Effect of Immediate Obtur...